Home with TablO outcoMEs (HOME) Registry
This study is collecting information about the Tablo Hemodialysis System. This device has been cleared by FDA for home use and is commercially available. The Tablo device will be used per the approved intended use and the instructions for use. If you are a patient with end stage renal disease (ESRD) that is being adequately treated by maintenance dialysis and have chosen to receive in-home care with Tablo at home as part of your standard medical care. The purpose of this study is to collect medical information and your experiences using an in-home hemodialysis system called the Tablo® Hemodialysis System.
Hormone Therapies & Other Systemic Therapies for Prostate Cancer | NYU Langone Health
Doctors at NYU Langone’s Perlmutter Cancer Center may prescribe prostate cancer medications such as hormone therapies for advanced cancer.
Hormone Therapy for Congenital Hypothyroidism | NYU Langone Health
Specialists at Hassenfeld Children’s Hospital at NYU Langone use thyroid hormone replacement to treat children with congenital hypothyroidism.
Hormone Therapy for Endometrial Cancer | NYU Langone Health
NYU Langone physicians prescribe hormone therapy for some women with endometrial cancer.
Horticultural Rehabilitation Program for Children | NYU Langone Health
Horticultural therapists from Rusk Rehabilitation use nature to aid patient healing at Hassenfeld Children’s Hospital at NYU Langone.
Horticultural Therapy for Adults | NYU Langone Health
Horticultural therapy experts at NYU Langone’s Rusk Rehabilitation uses nature and plants to reduce stress and aid recovery.
Hospital Compliance | NYU Langone Health
NYU Langone identifies and mitigates risks associated with billing, coding, and reimbursement for hospital-based services.
How to Make an Appointment at Perlmutter Cancer Center | NYU Langone Health
At Perlmutter Cancer Center, we help you take steps to make an appointment with one of our doctors.
How to Schedule an Imaging Appointment | NYU Langone Health
Schedule an imaging appointment at NYU Langone by calling us or through the NYU Langone Health app.
Human Epilepsy Project 3: Newly Diagnosed Idiopathic Generalized Epilepsy
The purpose of this research study is to identify factors that can predict how patients with idiopathic generalized epilepsy will do on a given seizure medication, whether they will have side effects, and whether they will have more seizures. These factors are called biomarkers. Biomarkers are an indicator of a disease or pathology.